CNBC’s Jim Cramer took a shot at Tesla during a Mad Money segment this week where he criticized the company’s business model, honing in on CEO Elon Musk’s leadership tactics. “If you’re an analyst, I think the only way to handle an Elon Musk conference call is to take some mind-altering drugs,” Cramer said.
